A strain of Bacillus deserticola that inhibits lactic acid bacteria in fermented grains
The inhibition of lactic acid bacteria by Bacillus Sonos Desert JLBM 13002 has solved the problem of excessive lactic acid in fermentation of liquor, and has achieved improvement of the quality of liquor and lactic acid regulation. It is suitable for the production of sauce-flavored liquor.
Patent Information
- Application Number
- CN202310555950.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-17
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2043-05-17
AI Technical Summary
The prior art is difficult to effectively regulate the production of lactic acid during the fermentation of liquor, resulting in excessive lactic acid affecting the quality of the wine and inhibiting the growth of other microorganisms. Process changes are likely to disrupt the normal fermentation process, and there is no scientific basis.
Bacillus sonorensis JLBM 13002 is provided. This strain can effectively inhibit a variety of lactic acid bacteria without significant inhibition on functional yeast. It is used to regulate lactic acid production during fermentation of liquor, through its fermentation products and Antibacterial proteins achieve inhibition of lactic acid bacteria.
It has achieved effective regulation of lactic acid in liquor, improved the quality of liquor, and did not affect the normal fermentation process. It has targeted regulation characteristics and is suitable for the production of sauce-flavored liquor.
Smart Images

Figure CN116790421B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a Sonos Desert Bacillus strain for inhibiting lactic acid bacteria in fermented grains, belonging to the technical field of microbial technology. Background Art
[0002] Lactic acid bacteria are the dominant bacteria in the middle and late stages of liquor fermentation. Lactic acid and its derivative ethyl lactate, the main metabolites of lactic acid bacteria, are important basic substances for Maotai-flavor liquor. The low volatility of lactic acid and the multiple rounds of fermentation of Maotai-flavor liquor will lead to the continuous accumulation of lactic acid. The right amount of lactic acid can regulate the fermentation process, but too much lactic acid will affect the quality of the liquor. In addition, during the fermentation process, too much lactic acid will inhibit the growth and metabolism of other microorganisms in the mash, leading to abnormal fermentation. Therefore, it is necessary to regulate the lactic acid production during the fermentation of Maotai-flavor liquor.
[0003] In addition to possibly disrupting the normal fermentation process, the specific operation of the process needs to rely more on long-term production experience, and it is impossible to explain the scientific basis. However, the intervention and regulation of Daqu components and microbial communities through microbial means to prepare bio-fortified Daqu can not only improve the overall quality of liquor, but also achieve targeted regulation of a specific product.
[0004] In the past, the methods of regulating and controlling lactic acid mainly focused on controlling the growth of microorganisms with lactic acid synthesis ability by changing the production process, so as to indirectly achieve effective control of lactic acid accumulation concentration. For example, (1) regulating Daqu; by regulating the amount of lactic acid bacteria in Daqu, lactic acid can be effectively controlled at a lower level; (2) regulating the fermentation rate; regulating the fermentation rate to reduce lactic acid production starts from three links: the first is the starch supply link; the second is the control of the lower cellar temperature link; the third is the provision of inhibition link, and the addition of fumaric acid can inhibit the formation of ethyl lactate. In addition to the possibility of disrupting the normal fermentation process, the specific operation of the process needs to rely more on long-term production experience, and it is impossible to clarify the scientific basis. However, by intervening and regulating the Daqu components and microbial communities through microbial means, the inhibition of lactic acid-producing microorganisms can be directly achieved, which can not only achieve the overall improvement of the quality of liquor, but also achieve the directional regulation of a specific product.
[0005] Bacillus is a common type of microorganism in high-temperature Daqu due to its strong stress resistance, tolerance to high temperatures and low nutritional requirements. Its main functions are: 1. Hydrolyzing starch and protein; 2. Producing a variety of flavor characteristic substances; 3. Some Bacillus has antibacterial activity and can adjust the structure of the bacterial community.
[0006] At present, there are few studies on functional microorganisms that can effectively target and inhibit lactic acid bacteria in liquor production, or some existing inhibition methods will affect the production of liquor. It can be seen that screening functional microorganisms with excellent antibacterial effects, especially using the liquor brewing system as the screening source, can effectively achieve the regulation of lactic acid in liquor production, which has important production guidance and economic significance. Summary of the invention
[0007] In order to solve the above problems, the present invention provides a strain of Bacillus sonorensis JLBM 13002, which can not only effectively inhibit various lactic acid bacteria such as Lactobacillus plantarum, Lactobacillus pediglobulineum, Lactobacillus acidotolerant, Lactobacillus fermentum, etc. in liquor production, but also has no obvious inhibitory effect on the four main functional yeasts in liquor, namely Saccharomyces cerevisiae, Pichia pastoris, Schizosaccharomyces pombe group, and Bayer's yeast, thereby effectively realizing the regulation of lactic acid in liquor production without disturbing normal liquor fermentation.
[0008] The first object of the present invention is to provide a strain of Bacillus sonorensis JLBM 13002, which is deposited in the China Center for Type Culture Collection with a deposit number of CCTCCM 2023422 and a deposit date of March 28, 2023.
[0009] The Sonos Desert Bacillus CCTCC M 2023422 has the following characteristics:
[0010] (1) A variety of lactic acid bacteria that can be inhibited, including but not limited to Lactobacillus plantarum, Lactobacillus pediococcidioides, Lactobacillus acidotolerant, and Lactobacillus fermentum;
[0011] (2) There was no significant inhibitory effect on Saccharomyces cerevisiae, Pichia pastoris, Schizosaccharomyces pombe, and Bayer's yeast;
[0012] (3) Its fermentation products, sterile fermentation broth and crude antibacterial protein have an inhibitory effect on lactic acid bacteria;
[0013] (4) Morphological characteristics: Gram-positive bacteria, spore-forming, rod-shaped, without flagella;
[0014] (5) Colony characteristics: After culturing at 37°C for 24 h, the colony morphology of the bacteria formed colonies with neat edges, moist surface, and a slightly yellowish color on the agar plate.
[0015] (6) It is derived from the Daqu of Maotai-flavor liquor and can be used in the production of Maotai-flavor liquor.
[0016] The Sonos Desert Bacillus of the present invention uses bacterial universal primers 27F and 1492R to perform PCR on the screened strain, and the obtained PCR product is sent to Wuxi Tianlin Biotechnology Co., Ltd. for sequencing. BLAST is used to perform 16S rRNA sequence comparison on NCBI, and the homology is 99.79%. The nucleotide sequence is shown in SEQ ID NO: 1, and the strain is identified as Sonos Desert Bacillus.
[0017] The second object of the present invention is to provide a microbial agent containing the Sonos Desert Bacillus CCTCC M 2023422 of the present invention.
[0018] In one embodiment of the present invention, the microbial agent uses CCTCC M 2023422 as the main microorganism.
[0019] In one embodiment of the present invention, the viable count of CCTCC M 2023422 in the bacterial agent is 10 5 ~10 8 CFU / mL.
[0020] In one embodiment of the present invention, the bacterial concentration of CCTCC M 2023422 in the bacterial agent is in the range of 10 5 ~10 8 CFU / mL.
[0021] In one embodiment of the present invention, the bacterial agent is obtained by preparing the seed solution of CCTCC M 2023422 and then expanding the culture.
[0022] In one embodiment of the present invention, the microbial agent contains living cells of the CCTCC M2023422 strain of the present invention, dry cells of the CCTCC M 2023422 strain of the present invention obtained by freeze-drying, immobilized cells of the CCTCC M 2023422 strain of the present invention, a liquid agent of the CCTCC M 2023422 strain of the present invention, a solid agent of the CCTCC M 2023422 strain of the present invention, or the CCTCC M 2023422 strain of the present invention in any other form.
[0023] In one embodiment of the present invention, the bacterial agent also contains any strain of any species that can be used for fermented food or fermented food preparation, such as Bacillus licheniformis, Saccharomyces cerevisiae, Bacillus subtilis, etc.
[0024] The third object of the present invention is to provide a method for culturing the Sonos Desert Bacillus.
[0025] In one embodiment of the present invention, the culture medium selected for the Sonos Desert Bacillus is LB culture medium, with the formula: 10 g of tryptone, 5 g of yeast extract powder, 10 g of sodium chloride, and 1000 mL of distilled water.
[0026] In one embodiment of the present invention, the culture temperature of the Sonos Desert Bacillus is 37°C.
[0027] The fourth object of the present invention is to provide the application of the Sonos Desert Bacillus CCTCC M 2023422.
[0028] In one embodiment of the present invention, the application is used in the liquor fermentation process, specifically in the liquor mash.
[0029] In one embodiment of the present invention, the application is for inhibiting lactic acid bacteria; optionally, the lactic acid bacteria include but are not limited to Lactobacillus plantarum, Lactobacillus pedigree, Lactobacillus acid-resistant, and Lactobacillus fermentum.
[0030] In one embodiment of the present invention, the application is to utilize the fermentation supernatant of CCTCC M 2023422 or the antibacterial peptide substances produced by CCTCC M 2023422.
[0031] In one embodiment of the present invention, the method for preparing the sterile fermentation supernatant of Bacillus sonosus is to centrifuge the fermentation broth at 8000 rpm for 5 minutes to obtain a supernatant (4° C.), and filter the supernatant through a 0.22 μm filter membrane to obtain a sterile supernatant.
[0032] In one embodiment of the present invention, the method for preparing the antibacterial peptide substance is as follows: the culture solution is centrifuged at 4°C, 8000×g for 10 minutes to remove the bacteria, the supernatant is collected, ammonium sulfate is slowly added to the saturation of 60%, and the precipitation is carried out at 4°C overnight. The precipitate is collected by centrifugation at 8000×g for 10 minutes, and the precipitate is washed with PBS (pH
[0033] 7.0) and dilute to the same volume.
[0034] The present invention also provides a method for detecting the antibacterial effect of the Sonos Desert Bacillus CCTCC M 2023422 by using a modified agar diffusion method to inhibit lactic acid bacteria.
[0035] Beneficial effects of the present invention:
[0036] The present invention provides a Sonos Desert Bacillus CCTCC M 2023422. It is identified that the Desert Bacillus can inhibit the growth and acid production of main lactic acid bacteria in white wine fermented grains, which is specifically embodied in that: the fermentation product of the bacteria, the sterile fermentation liquid and the crude antibacterial protein are tested for antibacterial effect on lactic acid bacteria by using an agar diffusion method, and an obvious antibacterial circle appears; the sterile fermentation liquid of the Desert Bacillus is added to a liquid culture medium inoculated with lactic acid bacteria, and the growth amount (OD 600 The value) was lower than that of the control group without adding fermentation liquid, and the lactic acid content was significantly reduced; the bacteria and lactic acid bacteria were co-cultured for solid-state fermentation, the growth of lactic acid bacteria was significantly reduced and the lactic acid content was reduced; the fermentation supernatant of the desert Bacillus was treated with ammonium sulfate, and the antibacterial effect on lactic acid bacteria was detected by agar diffusion method, and obvious inhibition zones appeared. The results showed that the strain had a significant inhibitory effect on the production of lactic acid bacteria.
[0037] The Sonos Desert Bacillus CCTCC M 2023422 of the present invention has no obvious inhibitory effect on the four main functional yeasts in Maotai-flavor liquor.
[0038] The Sonos Desert Bacillus CCTCC M 2023422 of the invention is derived from Maotai-flavor liquor Daqu and can be used for Maotai-flavor liquor production.
[0039] Biomaterial Deposit
[0040] Bacillus sonorensis JLBM 13002 is deposited in the China Center for Type Culture Collection with the deposit number CCTCC M 2023422 and the deposit date is March 28, 2023. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 Flow chart for screening Daqu with inhibitory effect on lactic acid bacteria.
[0042] Figure 2 Flow chart for screening functional microorganisms that have inhibitory effects on lactic acid bacteria.
[0043] Figure 3 This is the colony growth picture and scanning electron microscope image of Sonos Desert Bacillus on LB medium.
[0044] Figure 4 This is the phylogenetic tree constructed based on the 16S rRNA gene sequence of Bacillus sonosus. The sequence numbers of the other strains are shown in Table 1.
[0045] Figure 5 The operation process of the agar diffusion method was improved.
[0046] Figure 6This is the antibacterial effect of Sonos Desert Bacillus culture, fermentation broth and antibacterial protein on lactic acid bacteria; the four holes counterclockwise from the upper right corner are added with sterile water, culture, sterile fermentation broth and antibacterial protein respectively.
[0047] Figure 7 This is the antibacterial effect of Sonos Desert Bacillus culture, fermentation broth and antibacterial protein on yeast; the four holes counterclockwise from the upper right corner are added with sterile water, culture, sterile fermentation broth and antibacterial protein respectively.
[0048] Figure 8 The changes in pH and lactic acid in liquid culture of Sonos Desert Bacillus and acid-tolerant Lactobacillus.
[0049] Fig. 9 The changes in lactic acid content under solid-state fermentation co-culture of Sonos Desert Bacillus and acid-tolerant Lactobacillus.
[0050] Fig.10 The changes in lactic acid content under solid-state fermentation co-culture of Bacillus of Sonos Deserticola, Pediococcus acidilactici and Lactobacillus plantarum. DETAILED DESCRIPTION
[0051] Sorghum juice medium: sorghum: water = 1:4 (M:V), add amylase to cook and liquefy, add saccharifying enzyme at 60°C, filter and centrifuge, and adjust the sugar content to 7°Bx.
[0052] Sorghum solid culture medium: sorghum: water = 1:4 (M:V), add amylase, stir and cook, and add saccharifying enzyme at 60℃.
[0053] The expansion culture medium is TB (Terrific Broth) medium: 2% tryptone, 2.4% yeast extract, 0.4% glycerol, 72mM K2HPO4, 17mM KH2PO4.
[0054] The strains used in the antibacterial experiment: Lactobacillus plantarum CGMCC No.12717 (disclosed in CN106479922A with a publication date of 2017-03-08), Pediococcus acidilactici CGMCC No.22237 (disclosed in CN114395513A with a publication date of 2022-04-26), Lactobacillus acidophilus CGMCC No.14059 (disclosed in CN107058196A with a publication date of 2017-08-18), Lactobacillus fermentum CGMCC No.12716 (disclosed in CN106479923A with a publication date of 2017-03-08); Saccharomyces cerevisiae CGMCC No.19337 (disclosed in CN111254085A with a publication date of 2020-06-09), Pichia pastoris CGMCC No.14068 (already disclosed in CN114561305A with a publication date of 2022-05-31), Schizosaccharomyces pombe group CGMCC No.12715 and Bayer binding yeast Zygosaccharomyces bailii C7 (already disclosed in CN106635848A with a publication date of 2017-05-10).
[0055] Example 1: Screening of Daqu for Inhibiting Lactic Acid Bacteria
[0056] A piece of Daqu with the most obvious antibacterial effect was obtained from the high-temperature Daqu used in Maotai-flavor liquor. It was then used as the screening source for the next step of screening of antibacterial microorganisms. The specific operations were as follows:
[0057] 20 g of each Daqu block was ground and then added with 100 ml of sorghum juice medium, and cultured in a 250 ml conical flask at 37 ° C for 1 day (200 rpm). The Daqu enrichment solution was then centrifuged (4 ° C, 8000 rpm, 10 min), and the supernatant was filtered through a 0.22 μm filter membrane to obtain a sterile supernatant. The supernatant was added to the lactic acid bacteria seed solution at a ratio of 20% (the lactic acid bacteria inoculation amount was 0.1%, MRS medium 2 mL, and supernatant was added 0.5 mL). The lactic acid bacteria without the addition of sterile fermentation solution were used as the control group (MRS medium 2.5 mL). After culturing for 1 day, the OD was measured with an enzyme marker. 600 If it is lower than the control group, it can be preliminarily shown that the Daqu supernatant has a certain inhibitory effect on the lactic acid bacteria. Figure 1 .
[0058] Example 2: Screening of microorganisms that inhibit lactic acid bacteria
[0059] The present invention separates and screens functional strains capable of inhibiting lactic acid bacteria from the antibacterial Daqu screened out in Example 1. The specific operation of this method is as follows:
[0060] First, dilute the antibacterial Daqu enrichment solution in order (10 -3 , 10 -4 , 10 -5 , 10 -6 ) was plated and cultured at 37°C for 48h, and then multiple single colonies were quickly screened from the plate and pure cultured in a 96-well plate for 48h (the culture medium was a nutrient-rich sorghum juice culture medium), and then the sterile fermentation liquid was collected (the method was the same as in Example 1) and added to the seed liquid of lactic acid bacteria. The lactic acid bacteria without the addition of the sterile fermentation liquid were used as the control group, and the OD was measured after culturing for 1 day. 600 If it is lower than the control group, it can be preliminarily shown that it has a certain inhibitory effect on the lactic acid bacteria. Compared with the plate agar diffusion method, this method is simpler to operate and is suitable for screening bacteria in a wide range of screening samples. Figure 2 .
[0061] Example 3: Obtaining Sonos Desert Bacillus
[0062] From the antibacterial Daqu of Maotai-flavor liquor screened in Example 1, a strain of Bacillus with inhibitory effect on lactic acid bacteria was screened using the process of Example 2, and it was identified as Sonos Desert Bacillus (named JLBM 13002) by 16S rRNA sequencing. The colony morphology of the bacteria was observed and photographed by scanning electron microscope.
[0063] (1) Morphological observation:
[0064] The strain was inoculated into broth medium (LB) and was able to grow. The colony morphology was characterized by the formation of slightly yellowish, opaque colonies with neat edges and moist surfaces on the agar plate. The cold field emission scanning electron microscope (FESEM) showed that the strain was rod-shaped, without flagella and with spores, which met the basic characteristics of Bacillus (see Figure 3 ).
[0065] (2) Molecular identification:
[0066] Use an inoculation loop to pick a single colony of the bacteria and inoculate it into LB broth medium, and culture it at 37℃, 180rpm for 24h. Take out 0.7mL of bacteria and put it into a 2mL centrifuge tube, add 0.7mL nucleic acid extract (25:24:1) and 0.1mm glass beads, then use a cell disruptor to break it (1min, 60hz), centrifuge (4℃, 10000rpm, 10min), draw the supernatant into a 1.5mL centrifuge tube, add an equal volume of nucleic acid extract (24:1), centrifuge (4℃, 10000rpm, 10min), draw the supernatant into a 1.5mL centrifuge tube, add twice the volume of anhydrous ethanol, store it in a refrigerator for 2h (-20℃), centrifuge (4℃, 10000rpm, 10min), empty the supernatant, concentrate and dry, add 20μL sterile water, and the DNA template is obtained.
[0067] PCR amplification was performed using the universal primers 27F and 1525R of the bacterial 16S rRNA gene; PCR amplification and sequencing analysis of 16S rRNA: PCR reaction system is 25μl: PCR Master Mix 12.5μL, 1μL of each upper and lower primer, 1μL of DNA template, and the rest is made up with sterile water. PCR reaction conditions: 95℃
[0068] 3min; 95℃30s, 55℃30s, 72℃90s, 30 cycles; 72℃10min. The PCR product was detected by agarose gel electrophoresis and sent to Wuxi Tianlin Biological Co., Ltd. for sequencing. The sequencing results were compared and analyzed in the nucleic acid database on the NCBI website. It was found that the 16S rRNA nucleotide sequence of Sonos desert Bacillus JLBM 13002 (as shown in SEQ ID NO.1) and the Sonos desert Bacillus SRCM101395 16S rRNA gene (GenBank sequence number: GCA_002202015.1) were 99.73% similar, confirming that the tested bacteria were Sonos desert Bacillus. The genetic evolution tree constructed based on the 16S rRNA gene sequence is shown in Figure 4 .
[0069] Table 1 Phylogenetic tree reference strain genome information
[0070]
[0071] Bacillus sonosus JLBM 13002 was deposited in the China Center for Type Culture Collection with the deposit number CCTCC M 2023422 and the deposit date of March 28, 2023.
[0072] Example 4: Application of JLBM 13002 in antibacterial properties
[0073] (1) Preparation of JLBM 13002 culture:
[0074] The Sonos Desert Bacillus JLBM 13002 was inoculated into a test tube containing 5 mL of TB broth medium and cultured at 37° C. and 200 rpm in a shaking incubator for 24 hours to obtain a culture of JLBM 13002.
[0075] (2) Preparation of sterile fermentation broth:
[0076] The Sonos Desert Bacillus JLBM 13002 was inoculated into a 3000mL conical flask containing 1000mL TB culture medium, cultured at 37°C, 200rpm in a shaking incubator for 48h, centrifuged at 8000rpm for 10min, the supernatant was taken, filtered through a 0.22μm filter membrane, and the supernatant was collected as the JLBM 13002 sterile fermentation broth.
[0077] (3) Using ammonium sulfate precipitation method to crudely extract antibacterial protein:
[0078] Take 400 mL of fermentation supernatant, add ammonium sulfate to the supernatant while stirring to make its saturation reach 70%, and precipitate overnight at 4°C. Centrifuge at 8000 rpm for 10 min to collect the precipitate, dissolve the precipitate with PBS (pH 7.0) and make up to 20 mL, and determine its antibacterial activity.
[0079] (4) Improved agar diffusion method to determine the antibacterial effect:
[0080] a: Plate preparation
[0081] Prepare MRS agar medium, about 25 mL / plate, and place the sterilized medium at a temperature of about 30°C. Then add 0.1% of the lactic acid bacteria seeds to be tested, mix well, pour the plate, cool and solidify, and place it in a 4°C refrigerator to cool for 20 minutes. Then use a sterile pipette to dig holes on the plate; see Figure 5 .
[0082] b: Cultivation of lactic acid bacteria to be tested
[0083] The lactic acid bacteria to be tested were inoculated into 5 mL of MRS medium and cultured at 37°C for 24 h;
[0084] c: Antibacterial experiment
[0085] In the holes on the plate, 50 μl of JLBM 13002 strain culture, sterile fermentation broth, antibacterial crude protein, and sterile water (negative control) were added, marked, and the inhibition zone was measured after culturing at 37°C for 24 hours. The results showed that Figure 6It can be seen that on the plates of four different lactic acid bacteria (Lactobacillus plantarum, Pediococcus acidilactici, Lactobacillus acidotolerant, and Lactobacillus fermentum), the negative control of sterile water did not produce an inhibition zone, while the culture, sterile fermentation broth, and antibacterial protein all produced obvious inhibition zones, and the inhibition zone of the antibacterial protein was significantly larger than that of the culture and sterile fermentation broth, which indicates that the antibacterial effect of JLBM 13002 is mainly exerted by the antibacterial protein ( Figure 6 ).
[0086] (5) Antibacterial experiment on functional yeast
[0087] The JLBM 13002 strain culture, sterile fermentation broth, antibacterial crude protein and antibacterial test methods were all referred to the above examples. Saccharomyces cerevisiae, Pichia pastoris, Schizosaccharomyces pombe group and Bayer combined yeast were selected for antibacterial experiments. The results showed that JLBM 13002 had no antibacterial effect on the four yeast strains. Therefore, the antibacterial protein produced by JLBM 13002 may only act on bacteria, but not on fungi ( Figure 7 ).
[0088] Yeast culture medium was YPD medium: peptone 20 g·L- 1 , glucose 20 g·L- 1 , yeast extract 10 g·L- 1 ;
[0089] Example 5: Inhibition of Lactic Acid Bacillus by Sonos Desert Bacillus in Liquid Co-culture
[0090] Sonos Desert Bacillus JLBM 13002 and acid-tolerant Lactobacillus were co-inoculated into 50 mL sorghum juice liquid culture medium (inoculation amount was 0.1%, and pure culture of acid-tolerant Lactobacillus was used as the control group). After 3 days of culture, OD value, pH value and lactic acid content were measured. The results showed that the OD value of the co-culture group increased from 1.45 to 1.69, and the pH value increased from 3.62 to 3.89. The lactic acid content also decreased from 14.24 g / L to 9.78 g / L, with a decrease rate of 31.3% (such as Figure 8 ). Therefore, JLBM 13002 can inhibit the production of lactic acid by acid-tolerant Lactobacillus under liquid co-culture.
[0091] Example 6: Inhibition of acid-tolerant Lactobacillus by Sonos Desert Bacillus under solid co-culture
[0092] Sonos Desert Bacillus JLBM 13002 and acid-tolerant Lactobacillus were co-inoculated into 50 g sorghum solid culture medium (inoculation amount was 0.01%, and pure culture of acid-tolerant Lactobacillus was used as the control group). The lactic acid content was measured after 5 days of cultivation. The lactic acid content decreased from 8.56 g / kg sorghum to 6.61 g / kg sorghum, with a decrease rate of 22.8% (as shown in Figure 2). Fig. 9 ). Therefore, JLBM 13002 can inhibit the production of lactic acid by acid-tolerant Lactobacillus under solid co-culture.
[0093] Example 7: Inhibition of Pediococcus acidilactici and Lactobacillus plantarum by Bacillus deserticola in solid-state co-culture
[0094] Sonos Desert Bacillus JLBM 13002, Pediococcus acidilactici and Lactobacillus plantarum were co-inoculated into 50 g sorghum solid culture medium (inoculation amount was 0.01%, pure culture was used as the control group). The lactic acid content was measured after 5 days of culture. The lactic acid content in the Pediococcus acidilactici co-culture group decreased from 3.57 g / kg sorghum to 1.61 g / kg sorghum, with a decrease rate of 54.9%; the lactic acid content in the Lactobacillus plantarum co-culture group decreased from 5.26 g / kg sorghum to 4.10 g / kg sorghum, with a decrease rate of 22.1% (such as Fig.10 ). Therefore, JLBM 13002 can inhibit the production of lactic acid by Pediococcus acidilactici and Lactobacillus plantarum under solid co-culture.
[0095] The nucleotide sequence of the present invention is SEQ ID NO.1:
[0096] 16S rRNA nucleotide sequence of Sonos desert Bacillus JLBM 13002:
[0097]
[0098]
[0099] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A strain of Sonos Desert Bacillus ( Bacillus sonorensis ), characterized in that, The Sonos Desert Bacillus is deposited in the China Center for Type Culture Collection with a deposit number of CCTCC M 2023422 and a deposit date of March 28, 2023.
2. A microbial agent, characterized in that: Contains the Sonos Desert Bacillus according to claim 1.
3. The microbial agent according to claim 2, characterized in that: The number of viable bacteria of Sonos Desert Bacillus in the microbial agent is 10 5 ~10 8 CFU / mL.
4. The microbial agent according to claim 2, characterized in that: The microbial agent is a liquid agent or a solid agent.
5. Use of the Sonos Desert Bacillus according to claim 1 or the microbial agent according to any one of claims 2 to 4 in inhibiting lactic acid bacteria.
6. The use according to claim 5, characterized in that: The lactic acid bacteria include Lactobacillus plantarum, Lactobacillus pedicoccidioides, Lactobacillus acid-resistant, and Lactobacillus fermentum.
7. The use according to claim 5, characterized in that: The application is to use the aseptic fermentation supernatant of Sonos Desert Bacillus or the antibacterial protein produced by Sonos Desert Bacillus; The preparation method of the antibacterial protein is: The fermentation supernatant of Sonos Desert Bacillus was collected, ammonium sulfate was slowly added, precipitation was carried out overnight, and the precipitate was collected to obtain the antibacterial protein.
8. The use according to claim 7, characterized in that: The method for preparing the aseptic fermentation supernatant of Bacillus sonosus is to centrifuge the fermentation liquid to obtain the supernatant, and then filter the supernatant to obtain the aseptic fermentation supernatant.
Citation Information
Cited By
Method for improving quality of fermented grains of Baijiu
CN121406491A
